% | $
Quotes you view appear here for quick access.

Novadaq Technologies Inc. Message Board

glasgow_dad 3 posts  |  Last Activity: May 4, 2016 5:56 PM Member since: Mar 3, 2006
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    ??? What The Hell Do You Call That???

    by dblpro37 May 4, 2016 4:24 PM
    glasgow_dad glasgow_dad May 4, 2016 5:56 PM Flag

    Hi GSA - do you suspect/know something here? (Cough cough, "Intuitive?", cough cough)

    Or are you just trolling that guy? Seems unlike you... but you got my attention. LOL!

    I'd gleefully take a buyout @ $12.00 at this point (my basis is about 10.57 reverse-split adjusted). I'm sick to death of following this dog at this point (bad news, no revenue, assorted kinds of B.S. board room/CEO/proxy drama, etc.)

    Anyway, good luck to all of us with the buyout tomorrow! :-)

  • glasgow_dad glasgow_dad Apr 27, 2016 6:32 PM Flag

    Thank you!

  • Reply to

    15th Annual Needham Healthcare Conference

    by buzzybob Apr 12, 2016 11:32 AM
    glasgow_dad glasgow_dad Apr 12, 2016 2:13 PM Flag

    GSA - Agreed, no new information except confirming their current guidance is "about 32 to 35, 36% growth" and they "remain pretty comfortable with that guidance".

    The Investor Presentation is unchanged since January with the following exceptions:
    1. they updated Slide #10 now showing Q4 15 results
    2. they inserted one new slide (Slide #28) providing details regarding new molecules:

    " 5. New Imaging Molecules: Long Term Growth

    * First molecule (ICG) - blood flow in vessels, perfusion, lymph nodes
    - Product upgrades, new clinical applications

    * Second molecule - On track for announcement in late 2016
    - Critical anatomy
    - Enablement of certain new surgeries

    * Third molecule - Cancer margins "

    Arun provided an update regarding their four new product announcements:
    - they have already introduced two new products this year (color software upgrade, 5mm endoscope)
    - they will introduce the third product later this week (LUNA software upgrade)
    - they have the fourth product ready and will release it in Q3 (handheld SPY device).

    Other growth-driver color provided by Arun:
    - they will announce their second molecule before the end of 2016, it will provide impact in 2018.
    - they expect to announce results of the FILM Trial (SLN) in Q4-2016, impact in 2017.
    - they expect to release interim results of PILLAR III at SAGES 2017, impact in 2017.

    And lastly, no one asked any questions even though they had 4 minutes remaining... which struck me as slightly odd.


9.74+0.09(+0.93%)11:53 AMEDT